Free: 15-question metabolic assessment — reviewed by the HealthCalculus medical panel. Start now

Fasting · Moderate evidence

Intermittent Fasting (16:8): An honest audit

Time-restricted eating: 16-hour fast, 8-hour eating window daily

7/10

Sustainability

6/10

Short term

6/10

Long term

01The scorecard

Three numbers, one rubric

Sustainability0/10
Holds upStill running it in month twelve
Short-term effect0/10
MixedFirst 12 weeks in trials
Long-term effect0/10
MixedWhat survives at 12–24 months

Category

Fasting

Typical cost

No direct cost

First visible change

~14 days

Evidence rating

Moderate evidence

Studies cited

7

How to read these scores

Sustainability

Weighted heaviest. Adherence predicts outcome more reliably than macro split, so an approach nobody can keep scores low here even when the trial data looks good.

Short-term effect

A high number here alone means very little. Water and glycogen move fast, and almost every restrictive protocol looks impressive at week four.

Long-term effect

Where short-term and long-term diverge sharply, you are usually looking at a regain mechanism built into the design — not a willpower failure.

02The pitch

What it promises — and how it says it works

The claim

What it claims

Time-restricted eating (TRE) — popularised as 16:8 — confines all daily food intake to an 8-hour window, with the remaining 16 hours fasted (water, black coffee, tea allowed). Proponents (Panda, Mattson, Fung, Berg) claim TRE produces fat loss, autophagy upregulation, improved insulin sensitivity, lower fasting glucose, longer healthspan, and reduced inflammation — independent of total calorie intake. Stronger claims include cellular cleanup ('autophagy'), neurogenesis, and life-extension effects extrapolated from animal studies. The mainstream version is more modest: TRE is a behavioural tool that helps many people eat less by structurally limiting opportunities to eat, with secondary metabolic effects mediated by circadian alignment and reduced grazing.

The mechanism

How it is supposed to work

TRE works through three plausible mechanisms. First, behavioural: a shorter eating window typically reduces total intake even without conscious restriction, because two big meals beat three meals plus snacks for total calories in many populations. Second, circadian: aligning food intake to the active phase of the circadian cycle improves insulin sensitivity and lipid handling — Sutton 2018¹ showed early-window TRE improved metrics without weight loss. Third, hormonal: extended overnight fasts lower insulin, deplete glycogen, and increase fatty-acid oxidation. Autophagy increases meaningfully only at much longer fasts (24+ hours), so claims about cellular cleanup at 16 hours are largely speculative. The claim that fasting itself accelerates fat loss beyond an equivalent calorie deficit is not supported by metabolic-ward data.

03The evidence

What the research actually shows

Patterson 2017² reviewed early TRE evidence: weight loss comparable to continuous calorie restriction. Sutton 2018¹ tested early 6-hour TRE in prediabetic men and found improved insulin sensitivity, blood pressure, and oxidative stress without weight change. Lowe 2020 (TREAT trial)³ tested 16:8 vs three-meal control over 12 weeks and found no greater weight loss, but greater lean-mass loss in the TRE group. Liu 2022 (NEJM)⁴ extended this to a 12-month Chinese RCT: TRE plus calorie restriction was equivalent to calorie restriction alone — no added benefit from window timing. Catenacci 2016⁵ found alternate-day fasting matched continuous CR for weight loss but with higher dropout. The honest summary: TRE is a tool that helps some people eat less, not a metabolic switch that produces weight loss independent of calories. Effects on insulin sensitivity may exist independent of weight, especially with early-window TRE — but the effect size is modest.¹²³

Footnote numbers link to the full reference list at the foot of this page.

Evidence rating

Moderate evidence

Describes the quality and quantity of the peer-reviewed literature — trial count, duration, sample size and replication — not our opinion of the approach.

Early loss is not evidence. Glycogen carries roughly three grams of water per gram, so the first pounds on almost any restrictive protocol are largely water. What matters is what is still there at twelve and twenty-four months.

04The fit

Right person, wrong person

Almost nothing on this site is universally good or universally useless. The useful question is which body, kitchen and calendar an approach was built for.

Worth a trial

Who it works for

TRE works for adults who don't enjoy breakfast, who already eat 2-3 meals/day, who travel or have erratic morning schedules, and who find structural rules easier than calorie counting. It works for shift workers who can adapt their window to their actual active hours. It works as a maintenance pattern after weight loss — easier than continuous tracking. Adults with prediabetes and metabolic syndrome may see modest insulin-sensitivity benefit, especially with early-window protocols (eating 7am-3pm rather than 12pm-8pm). Works well for people with stable cortisol and good sleep — the protocol amplifies stress, so prerequisites matter.

Look elsewhere

Who it fails

TRE fails for women with menstrual-cycle disruption or perimenopausal hormonal turbulence — extended fasting can amplify cortisol elevation in this population and worsen sleep. It fails for adults with high training volumes who need fueling around workouts. It fails for adults with disordered-eating histories where the structural rule reinforces restrictive thinking. It fails as a magic bullet — many adopters quit within 12 weeks once they realise the metabolic benefits over an equivalent calorie deficit are modest. It can fail when the eating window becomes a binge window, with total intake higher than three normal meals would be. It tends to fail when paired with high stress and poor sleep — adding fasting on top of an already-stressed system pushes cortisol further up.

05The verdict

16:8 TRE is a legitimate behavioural tool with a modest, real-world evidence base. It helps many people eat less without explicit tracking, may produce small insulin-sensitivity benefits independent of weight (especially with early-window protocols), and is broadly safe for healthy adults. The strongest claims about autophagy, longevity, and unique fat-burning effects are not supported at 16-hour fasts — those mechanisms operate at much longer timescales. We recommend 16:8 as a candidate behavioural pattern for adults who eat 2-3 meals/day naturally, have good sleep and moderate stress, and don't have hormonal disruption or eating-disorder history. Don't expect a metabolic transformation; expect a structured way to eat less with less daily decision fatigue.

Written against the rubric, not against a sponsor. Individual response varies and no outcome is guaranteed.

06The alternative

What to do instead

If 16:8 doesn't fit, try 14:10 (more forgiving, similar benefit for many) or simply cut snacks between three real meals. If you're female with cycle disruption, focus on adequate protein and resistance training before adding fasting. If you have high stress and poor sleep, fix those first — fasting amplifies both.

Not sure which fits

Get a read on your profile

Fifteen questions, roughly two minutes, no email wall on the result. Returns a starter protocol matched to your metabolic situation.

Take the assessment
07Common questions

Straight answers

Intermittent Fasting (16:8), without the spin

We score Intermittent Fasting (16:8) 7/10 for sustainability, 6/10 for short-term effect and 6/10 for long-term effect. A gap between the short-term and long-term numbers is the single most common pattern in this index — an approach can move the scale quickly and still leave almost nothing behind eighteen months later.

Sustainability is weighted heaviest for a reason: across head-to-head trials, adherence predicts outcome more reliably than which named diet you picked. A protocol you abandon in week six did nothing at all.

Sustainability70%

Can you still be doing this in month twelve?

Short-term effect60%

First 12 weeks in controlled trials

Long-term effect60%

What survives at 12–24 months

Educational summaries of published research. Individual response varies and no outcome is guaranteed.

08Sources

References

  1. 01Patterson RE, Sears DD (2017). Metabolic Effects of Intermittent Fasting. Annual Review of Nutrition. PubMed 28715993
  2. 02Sutton EF et al. (2018). Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss. Cell Metabolism. PubMed 29754952
  3. 03Lowe DA et al. (2020). Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity (TREAT). JAMA Internal Medicine. PubMed 32986097
  4. 04Liu D et al. (2022). Calorie restriction with or without time-restricted eating in weight loss. New England Journal of Medicine. PubMed 35443107
  5. 05Varady KA et al. (2021). Cardiometabolic Benefits of Intermittent Fasting. Annual Review of Nutrition. PubMed 34633860
  6. 06Catenacci VA et al. (2016). A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction. Obesity. PubMed 27569118
  7. 07Garaulet M et al. (2013). Timing of food intake predicts weight loss effectiveness. International Journal of Obesity. PubMed 23357955
09Your turn

Did Intermittent Fasting (16:8) not work for you?

That is the rule rather than the exception, and it is usually a design problem in the protocol rather than a character problem in you. The assessment reads your situation and points you at the approach the research supports for that profile.

  • Free, with no email wall on the result
  • Fifteen questions, roughly two minutes
  • Returns a starter protocol matched to your profile
  • Every recommendation links back to its research

Educational only, not medical advice. This audit summarises published research and is not a diagnosis, a prescription, or a treatment plan. Consult your physician before major dietary changes or altering prescribed medication. These statements have not been evaluated by the Food and Drug Administration. Individual results vary; no outcome is guaranteed.